Schedule of computation of basic and diluted net income (loss) per share |
The following table sets forth the computation of basic and diluted net income per common share: | | | | | | | | | | | | | | | | | | | | | | | | | Thirteen Weeks Ended | | Twenty-Six Weeks Ended | | June 27, 2025 | | June 28, 2024 | | June 27, 2025 | | June 28, 2024 | Net income per share: | | | | | | | | Basic | $ | 0.55 | | | $ | 0.41 | | | $ | 0.81 | | | $ | 0.46 | | Diluted | $ | 0.49 | | | $ | 0.37 | | | $ | 0.74 | | | $ | 0.44 | | Weighted average common shares: | | | | | | | | Basic | 38,883,019 | | | 37,924,931 | | | 38,788,843 | | | 37,871,080 | | Diluted | 46,031,127 | | | 45,947,728 | | | 46,055,696 | | | 45,959,061 | |
|
Schedule of reconciliation of net income (loss) per common share |
Reconciliation of net income per common share: | | | | | | | | | | | | | | | | | | | | | | | | | Thirteen Weeks Ended | | Twenty-Six Weeks Ended | | June 27, 2025 | | June 28, 2024 | | June 27, 2025 | | June 28, 2024 | Numerator: | | | | | | | | Net income | $ | 21,241 | | | $ | 15,524 | | | $ | 31,529 | | | $ | 17,455 | | Add effect of dilutive securities | | | | | | | | Interest on convertible notes, net of tax | 1,226 | | | 1,322 | | | 2,451 | | | 2,628 | | Net income available to common shareholders | $ | 22,467 | | | $ | 16,846 | | | $ | 33,980 | | | $ | 20,083 | | Denominator: | | | | | | | | Weighted average basic common shares outstanding | 38,883,019 | | | 37,924,931 | | | 38,788,843 | | | 37,871,080 | | Dilutive effect of unvested common shares | 581,013 | | | 573,930 | | | 700,950 | | | 642,767 | | Dilutive effect of stock options and warrants | 72,125 | | | 56,050 | | | 70,933 | | | 52,397 | | Dilutive effect of convertible notes | 6,494,970 | | | 7,392,817 | | | 6,494,970 | | | 7,392,817 | | Weighted average diluted common shares outstanding | 46,031,127 | | | 45,947,728 | | | 46,055,696 | | | 45,959,061 | |
|
Schedule of dilutive securities that have been excluded from the calculation of diluted net income (loss) per common share |
Potentially dilutive securities that have been excluded from the calculation of diluted net income per common share because the effect is anti-dilutive are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Thirteen Weeks Ended | | Twenty-Six Weeks Ended | | June 27, 2025 | | June 28, 2024 | | June 27, 2025 | | June 28, 2024 | Restricted share awards (“RSAs”) and restricted stock units (“RSUs”) | 215,454 | | | 160,273 | | | 259,505 | | | 286,769 | | | | | | | | | | | | | | | | | |
|